摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4,5-dimethyl-1,3,2-dioxaphospholan-2-ium 2-oxide | 16352-17-3

中文名称
——
中文别名
——
英文名称
4,5-dimethyl-1,3,2-dioxaphospholan-2-ium 2-oxide
英文别名
2-hydro-4,5-dimethyl-2-oxo-1,3,2-dioxaphospholane;4,5-dimethyl-1,3,2λ5-dioxaphospholane 2-oxide;2-hydro-2-oxo-4,5-dimethyl-1,3,2-dioxaphospholane;4,5-dimethyl-1,3,2-dioxaphospholane 2-oxide;4,5-dimethyl-[1,3,2]dioxaphospholane 2-oxide;phosphonic acid-(1,2-dimethyl-ethanediyl ester);4,5-Dimethyl-2-oxo-[1,3,2λ5]dioxaphospholan
4,5-dimethyl-1,3,2-dioxaphospholan-2-ium 2-oxide化学式
CAS
16352-17-3;26349-89-3;26349-90-6;26349-91-7
化学式
C4H9O3P
mdl
——
分子量
136.087
InChiKey
UGKNFCJGEKQALI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    60-63 °C(Press: 0.03 Torr)

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    8.0
  • 可旋转键数:
    0.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    35.53
  • 氢给体数:
    0.0
  • 氢受体数:
    3.0

SDS

SDS:d81cb02eca48bca92f0a6190459a81dd
查看

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] METHOD FOR THE SYNTHESIS OF HETEROCYCLIC HYDROGEN PHOSPHINE OXIDE<br/>[FR] PROCÉDÉ POUR LA SYNTHÈSE D'UN OXYDE DE D'HYDROGÉNOPHOSPHINE HÉTÉROCYCLIQUE
    申请人:STRAITMARK HOLDING AG
    公开号:WO2016026871A1
    公开(公告)日:2016-02-25
    The present invention is related to a method for the synthesis of a heterocyclic hydrogen phosphine oxide, having the general formula (I), wherein: - R is a aliphatic or aromatic divalent group optionally comprising one or more heteroatoms and optionally comprising one or more substituents and - X and Y are independently selected from -O-, -C(O)O- and -NR'- wherein R' is a monovalent group optionally comprising one or more heteroatoms comprising the steps of: a) forming a reaction mixture by mixing a compound having the general formula HX-R-YH and tetraphosphorus hexaoxide; b) recovering the resulting compound comprising the heterocyclic hydrogen phosphine oxide.
    本发明涉及一种合成杂环氢膦氧化物的方法,其具有通式(I),其中:- R是一种脂肪或芳香双价基团,可选地包含一个或多个杂原子,也可选地包含一个或多个取代基;- X和Y分别选自-O-,-C(O)O-和-NR'-,其中R'是一种可选地包含一个或多个杂原子的单价基团,包括以下步骤:a)通过混合具有通式HX-R-YH和六氧化四的化合物形成反应混合物;b)回收包含杂环氢膦氧化物的所得化合物。
  • Celebrating 20 Years of SYNLETT - Special Essay: General Procedure for the Palladium-Catalyzed Selective Hydrophosphorylation of Alkynes
    作者:Valentine Ananikov、Irina Beletskaya、Levon Khemchyan
    DOI:10.1055/s-0029-1217739
    日期:2009.9
    A novel catalytic system has been developed to accomplish the hydrophosphorylation of terminal and internal alkynes with high isolated yields (up to 96%) and excellent regio- and stereo­selectivity (>99:1). The key factor was to apply a low-ligated palladium/triphenylphosphane (1:2) catalytic system in the presence of a catalytic amount of trifluoroacetic acid. The catalytic system so developed has been applied successfully to permit the formation of diverse alkenylphosphonates utilizing a variety of available H-phos­phonates and alkynes.
    开发了一种新型催化体系,以高分离收率(高达96%)和优异的区域及立体选择性(>99:1)实现末端和内部炔烃的亲磷酸化。关键因素是在三氟乙酸催化剂量的存在下,应用低配位/三苯基膦(1:2)催化体系。所开发的催化体系已成功应用于利用多种可用H-膦酸酯和炔烃形成多种烯基膦酸酯。
  • New method of alkylene phosphonate preparation
    作者:Pawel Klosinski
    DOI:10.1016/s0040-4039(00)88906-6
    日期:1990.1
    A new method of alkylene phosphonate preparation has been elaborated, based on the reaction of the corresponding cyclic ethers and phosphonic acid in the presence of acetic anhydride.
    基于相应的环醚膦酸乙酸酐存在下的反应,详细阐述了一种制备亚烷基膦酸酯的新方法。
  • Acid-Free Nickel Catalyst for Stereo- and Regioselective Hydrophosphorylation of Alkynes: Synthetic Procedure and Combined Experimental and Theoretical Mechanistic Study
    作者:Valentine P. Ananikov、Levon L. Khemchyan、Irina P. Beletskaya、Zoya A. Starikova
    DOI:10.1002/adsc.201000606
    日期:2010.11.22
    situ from nickel bis(acetylacetonate) [Ni(acac)2] precursor and bis(diphenylphosphino)ethane (DPPE) ligand has shown excellent performance in the hydrophosphorylation of alkynes. Markovnikov-type regioselective addition to terminal alkynes and stereoselective addition to internal alkynes were carried out with high selectivity without an acidic co-catalyst (in contrast to the palladium/acid catalytic system)
    由双(乙酰丙酮酸[Ni(acac)2原位制备的催化剂]前体和双(二苯基膦基乙烷DPPE配体炔烃的加氢磷酸化中表现出出色的性能。在没有酸性助催化剂的情况下(与/酸催化体系相反),以高选择性进行了向末端炔烃的马尔科夫尼科夫区域选择性加成和向内部炔烃的立体选择性加成。在开发的催化体系中,各种H-膦酸酯和炔烃反应平稳,收率高达99%。通过实验(NMR,ESI-MS,X射线)和理论(密度泛函计算)研究揭示了催化剂活化和CP键形成的机理。首次报道了炔烃属配位体中插入的两种不同途径。
  • Cyclic organophosphorus compounds. I. Synthesis and infrared spectral studies of cyclic hydrogen phosphites and thiophosphites
    作者:A. Zwierzak
    DOI:10.1139/v67-411
    日期:1967.11.1
    A general synthetic procedure leading to cyclic hydrogen phosphites has been devised. The effect of solvent on the P==O and P—H infrared stretching modes of cyclic hydrogen phosphites and thiophosphites has been studied. It is concluded that association of cyclic hydrogen phosphites is attributable to dipole–dipole interactions rather than to hydrogen bonding.
    已经设计了导致环状亚磷酸氢酯的一般合成程序。研究了溶剂对环状亚磷酸氢酯和亚磷酸酯的 P==O 和 P-H 红外伸缩模式的影响。结论是环状亚磷酸氢盐的缔合归因于偶极-偶极相互作用而不是氢键。
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)